Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment

Jeong Min Hwang, Christopher A. Girkin, Julian D. Perry, James C. Lai, Neil R. Miller, David B. Hellmann

Research output: Contribution to journalArticle

Abstract

PURPOSE: To report the development of a bilateral ocular ischemic syndrome despite corticosteroid treatment in a patient with giant cell arteritis. METHOD: Case report. RESULTS: Despite receiving high-dose intravenous methylprednisolone and oral prednisone for biopsy-proven giant cell arteritis that presented as a severe anterior ischemic optic neuropathy in the right eye, a patient developed progressive ocular ischemia in that eye as well as an ocular ischemic syndrome in the fellow eye. CONCLUSIONS: Some patients with giant cell arteritis, possibly patients with other underlying systemic vasculopathies, are refractory to what should be adequate treatment with systemic corticosteroids and may develop a bilateral ocular ischemic syndrome.

Original languageEnglish (US)
Pages (from-to)102-104
Number of pages3
JournalAmerican journal of ophthalmology
Volume127
Issue number1
DOIs
StatePublished - Jan 1999

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment'. Together they form a unique fingerprint.

  • Cite this